Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · Real-Time Price · USD
5.25
-0.04 (-0.76%)
At close: Sep 5, 2025, 4:00 PM
5.21
-0.04 (-0.76%)
After-hours: Sep 5, 2025, 5:55 PM EDT

Evoke Pharma Revenue

Evoke Pharma had revenue of $3.75M in the quarter ending June 30, 2025, with 47.06% growth. This brings the company's revenue in the last twelve months to $12.79M, up 70.02% year-over-year. In the year 2024, Evoke Pharma had annual revenue of $10.25M with 97.84% growth.

Revenue (ttm)
$12.79M
Revenue Growth
+70.02%
P/S Ratio
1.08
Revenue / Employee
$4,264,953
Employees
3
Market Cap
10.87M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202410.25M5.07M97.84%
Dec 31, 20235.18M2.67M106.51%
Dec 31, 20222.51M890.57K55.04%
Dec 31, 20211.62M1.60M6,929.00%
Dec 31, 202023.02K--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.